Annals of Surgical Oncology

, Volume 20, Issue 13, pp 4080–4089 | Cite as

Extrathoracic Location and “Borderline” Histology are Associated with Recurrence of Solitary Fibrous Tumors After Surgical Resection

  • Breelyn A. Wilky
  • Elizabeth A. Montgomery
  • Angela A. Guzzetta
  • Nita Ahuja
  • Christian F. Meyer
Bone and Soft Tissue Sarcomas



Most solitary fibrous tumors (SFTs) are cured by complete resection, but many recurrent and metastatic SFTs do not respond to treatment and are fatal. Malignant histology, defined by England’s pathologic criteria, is strongly associated with recurrence, but some benign SFTs still behave aggressively. Several studies have suggested that extrathoracic SFTs have a worse prognosis. We reviewed thoracic and extrathoracic SFTs from our institution to determine if extrathoracic location is associated with recurrence, independent of malignant histology.


With IRB approval, we retrieved patient pathology reports from the Johns Hopkins Surgical Pathology database between 1991 and 2011 and included 83 SFT patients in our analysis. Patient history and outcomes were obtained from the medical record and primary care physicians. Predictors of recurrence were analyzed by univariate and multivariate analysis and survival determined by the Kaplan–Meier method.


Of the 83 patients, 59 had extrathoracic SFTs in neurologic (n = 24), extremity or head/neck (n = 13), or visceral/intraabdominal (n = 22) sites. A total of 74 SFTs were classified benign and 9 as malignant. Of the 14 recurrences, 13 occurred in extrathoracic SFTs; only 7 were classified as malignant. Multivariate analysis confirmed that malignant histology had the strongest association with recurrence, but extrathoracic location also independently predicted recurrence. A total of 20 benign SFTs possessed 1 or more of England’s criteria but to an insufficient degree for malignant classification. These “borderline” SFTs were more likely to recur than benign SFTs without these features.


Extrathoracic and “borderline” SFTs with any of England’s criteria have a higher risk of recurrence.



Statistics support provided by the Biostatistics Center of the Johns Hopkins Bloomberg School of Public Health.




  1. 1.
    Robinson L. Solitary fibrous tumor of the pleura. Cancer Control. 2006;13:264–9.PubMedGoogle Scholar
  2. 2.
    Brunnemann R, Ro J, Ordonez N, Mooney J, El-Naggar A, Ayala A. Extrapleural solitary fibrous tumor: a clinicopathologic study of 24 cases. Mod Pathol. 1999;12:1034–42.PubMedGoogle Scholar
  3. 3.
    Chen H, Zeng X, Wu J, Dou YF, Wang Y, Zhong P, et al. Solitary fibrous tumor of the central nervous system: a clinicopathologic study of 24 cases. Acta Neurochir. 2012;154:237–48.PubMedCrossRefGoogle Scholar
  4. 4.
    Cranshaw I, Gikas P, Fisher C, Thway K, Thomas J, Hayes A. Clinical outcomes of extra-thoracic solitary fibrous tumours. Eur J Surg Oncol. 2009;35:994–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Erdag G, Qureshi H, Patterson J, Wick M. Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature. J Cutan Pathol. 2007;34:844–50.PubMedCrossRefGoogle Scholar
  6. 6.
    Gold JS, Antonescu CR, Hajdu C, Ferrone CR, Hussain M, Lewis JJ, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;94:1057–68.PubMedCrossRefGoogle Scholar
  7. 7.
    Hasegawa T, Matsuno Y, Shimoda T, Hasegawa F, Sano T, Hirohashi S. Extrathoracic solitary fibrous tumors: their histological variability and potentially aggressive behaviour. Hum Pathol. 1999;30:1464–73.PubMedCrossRefGoogle Scholar
  8. 8.
    Musyoki F, Nahal A, Powell T. Solitary fibrous tumor: an update on the spectrum of extrapleural manifestations. Skeletal Radiol. 2012;41:5–13.PubMedCrossRefGoogle Scholar
  9. 9.
    Herawi M, Epstein J. Solitary fibrous tumor on needle biopsy and transurethral resection of the prostate: a clinicopathologic study of 13 cases. Am J Surg Pathol. 2007;31:870–6.PubMedCrossRefGoogle Scholar
  10. 10.
    O’Regan E, Vanguri V, Allen C, Eversole L, Wright J, Woo S. Solitary fibrous tumor of the oral cavity: clinicopathologic and immunohistochemical study of 21 cases. Head Neck Pathol. 2009;3:106–15.PubMedCrossRefGoogle Scholar
  11. 11.
    Westra W, Gerald W, Rosai J. Solitary fibrous tumor: Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol. 1994;18:992–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Chilosi M, Facchetti F, Dei Tos AD, Lestani M, Morassi ML, Martignoni G, et al. bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol. 1997;181:362–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Cardillo G, Carbone L, Carleo F, Masala N, Graziano P, Bray A, et al. Solitary fibrous tumors of the pleura: an analysis of 110 patients treated in a single institution. Ann Thorac Surg. 2009;88:1632–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Okike N, Bernatz P, Woolner L. Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg. 1978;75:363–72.PubMedGoogle Scholar
  15. 15.
    England D, Hochholzer L, McCarthy M. Localized benign and malignant fibrous tumors of the pleura: A clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.PubMedCrossRefGoogle Scholar
  16. 16.
    Perrot Md, Fischer S, Bründler M, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74:285–93.CrossRefGoogle Scholar
  17. 17.
    Chang YL LY, Wu CT. Thoracic solitary fibrous tumor: clinical and pathological diversity. Lung Cancer. 1999;23:53–60.Google Scholar
  18. 18.
    Vallat-Decouvelaere A, Dry S, Fletcher C. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998;22:1501–11.PubMedCrossRefGoogle Scholar
  19. 19.
    Santos RS, Haddad R, Lima CE, Liu YL, Misztal M, Ferreira T, et al. Patterns of recurrence and long-term survival after curative resection of localized fibrous tumors of the pleura. Clin Lung Cancer. 2005;7:197–201.PubMedCrossRefGoogle Scholar
  20. 20.
    Park M, Araujo D. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Curr Opin Onc. 2009;21:327–31.CrossRefGoogle Scholar
  21. 21.
    Stacchiotti S, Negri T, Palassini E, Conca E, Gronchi A, Morosi C, et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol Cancer Ther. 2010;9:1286–97.PubMedCrossRefGoogle Scholar
  22. 22.
    Hajdu M, Singer S, Maki R, Schwartz G, Keohan M, Antonescu C. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. J Pathol. 2010;221:300–07.PubMedCrossRefGoogle Scholar
  23. 23.
    Yokoi T, Tsuzuki T, Yatabe Y, Suzuki M, Kurumaya H, Koshikawa T, et al. Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation. Histopathology. 1998;32:423–32.PubMedCrossRefGoogle Scholar
  24. 24.
    Lu C, Ji Y, Shan F, Guo W, Ding J, Ge D. Solitary fibrous tumor of the pleura: an analysis of 13 cases. World J Surg. 2008;32:1663–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Nielsen G, O’Connell J, Dickersin G, Rosenberg A. Solitary fibrous tumor of soft tissue: a report of 15 cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod Pathol. 1997;10:1028–37.PubMedGoogle Scholar
  26. 26.
    Sung S, Chang J, Kim J, Lee K, Han J, Park S. Solitary fibrous tumors of the pleura: surgical outcome and clinical course. Ann Thorac Surg. 2005;79:303–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Hanau C, Miettinen M. Solitary fibrous tumor: Histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Human Pathol. 1995;26:440–9.CrossRefGoogle Scholar
  28. 28.
    Insabato L, Siano M, Somma A, Gentile R, Santangelo M, Pettinato G. Extrapleural solitary fibrous tumor: a clinicopathologic study of 19 cases. Int J Surg Pathol. 2009;17:250–4.PubMedCrossRefGoogle Scholar
  29. 29.
    Suster S, Nascimento A, Miettinen M, Sickel J, Moran C. Solitary fibrous tumors of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol. 1995;19:1257–66.PubMedCrossRefGoogle Scholar
  30. 30.
    Tihan T, Viglione M, Rosenblum M, Olivi A, Burger P. Solitary fibrous tumors in the central nervous system: A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med. 2003;127:432–9.PubMedGoogle Scholar
  31. 31.
    Daigeler A, Lehnhardt M, Langer S, et al. Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues. BMC Surgery. 2006;6:10.PubMedCrossRefGoogle Scholar
  32. 32.
    Morimitsu Y, Nakajima M, Hisaoka M, Hashimoto H. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway. APMIS. 2000;108:617–25.PubMedCrossRefGoogle Scholar
  33. 33.
    Fukunaga M, Naganuma H, Nikaido T, Harada T, Ushigome S. Extrapleural solitary fibrous tumor: a report of seven cases. Mod Pathol. 1997;10:443–50.PubMedGoogle Scholar
  34. 34.
    Mentzel T, Bainbridge T, Katenkamp D. Solitary fibrous tumor: clinicopathological, immunohistochemical, and ultrastructural analysis of 12 cases arising in soft tissues, nasal cavity and nasopharynx, urinary bladder and prostate. Virchows Arch. 1997;430:445–53.PubMedCrossRefGoogle Scholar
  35. 35.
    Demicco E, Park M, Araujo D, Fox PS, Bassett RL, Pollock RE, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25:1298–306.PubMedCrossRefGoogle Scholar
  36. 36.
    Brozzetti S, D’Andrea N, Limiti MR, Pisanelli MC, De Angelis R, Cavallaro A. Clinical behavior of solitary fibrous tumors of the pleura: an immunohistochemical study. Anticancer Res. 2000;20:4701–6.PubMedGoogle Scholar
  37. 37.
    Nakamori M, Oda Y, Kurihara S, Tsuneyoshi M. Clinicopathological and immunohistochemical study of extrapleural and pleural solitary fibrous tumors: A special emphasis on the comparison between ordinary tumors and their malignant variant. Mol Med Rep. 2008;1:797–03.Google Scholar
  38. 38.
    Bouvier C, Metellus P, de Paula AM, Vasiljevic A, Jouvet A, Guyotat J, et al. Solitary fibrous tumors and hemangiopericytomas of the meninges: overlapping pathological features and common prognostic factors suggest the same spectrum of tumors. Brain Pathol. 2012;22:511–21.PubMedCrossRefGoogle Scholar
  39. 39.
    Mosquera J, Fletcher C. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component—is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.PubMedCrossRefGoogle Scholar
  40. 40.
    World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Fletcher CDM, Unni KK, Mertens F, eds. Lyon: IARC Press; 2002.Google Scholar
  41. 41.
    Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013;45:180–5.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2013

Authors and Affiliations

  • Breelyn A. Wilky
    • 1
  • Elizabeth A. Montgomery
    • 2
  • Angela A. Guzzetta
    • 3
  • Nita Ahuja
    • 3
  • Christian F. Meyer
    • 1
  1. 1.Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of PathologyJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of Surgery, Sidney Kimmel Comprehensive Cancer CenterJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations